August 30, 2014 10:31 AM ET

Company Overview of American Society Of Hematology

Company Overview

,  

United States

Key Executives for American Society Of Hematology

Vice-President
Councillor
Councillor
Age: 63
Director of Government Relations
Compensation as of Fiscal Year 2014.

American Society Of Hematology Key Developments

American Society Of Hematology Names Suzanne Leous as Director of Government Relations, Practice, and Scientific Affairs

The American Society of Hematology announced Suzanne (Suzy) Leous as he new Director of Government Relations, Practice, and Scientific Affairs, effective July 2, 2013. With more than 25 years of public policy experience and extensive work at ASH on policy and quality improvement programs, Ms. Leous brings a wealth of knowledge of the legislative process and clinical practice issues to her new role at ASH. She will primarily be responsible for working with Society volunteers, department directors, and the executive leadership to plan and implement Society activities related to the government affairs, practice, and scientific priorities as directed by the Society's Executive Committee. She will represent the Society's policy positions to Members of Congress, Federal Agencies, advocacy-related coalitions, and patient groups. In addition to her most recent role focusing on clinical practice issues and implementing quality improvement programs as Senior Manager of Quality and Practice at ASH, Ms. Leous was the Manager of Public Affairs at the American Society for Microbiology (ASM) for more than a decade.

American Society Of Hematology Posts Study on Role of Genetics, Modified Treatment Strategies to Improve Outcomes and Reduce Toxicity for Patients with Blood Cancers

American Society Of Hematology Posted Study on Role of Genetics, Modified Treatment Strategies to Improve Outcomes and Reduce Toxicity for Patients with Blood Cancers. Research identifying genetic factors that affect survival of patients with blood cancers and evaluating the effectiveness of modified treatment strategies to improve outcomes while reducing toxicity was presented on December 8 at the 54th Annual Meeting of the American Society of Hematology (ASH). According to a release, while the cancer research community has seen many significant therapeutic advances over the last decade, only recently have investigators identified how patients' individual genetic makeup influences their short- and long-term response to therapy, demonstrating that while the disease may respond positively to therapy, the patient may not. Current studies take these insights a step further, examining specific patient subpopulations to determine their risk for negative outcomes and whether early preventive interventions or treatment adjustments may help avoid treatment-related toxicity.

American Society of Hematology Launches ASH Foundation

American Society Of Hematology announced the creation of the ASH Foundation dedicated to curing blood diseases. The new foundation will complement and build on the work of the Society by harnessing the generosity of donors to expand the reach of successful ASH programs and develop new initiatives to address critical issues facing hematology researchers and clinicians. Through contributions from ASH members and supporters, the ASH Foundation will support a spectrum of new or enhanced ASH programming in three broad categories, including research, career development, and quality care and education, such as ASH's new Bridge Grants, as well as ASH's Scholar Awards, Global Programs, Clinical Research Training Institute and minority recruitment initiative. Because ASH covers all management and administrative costs for programs supported by the foundation, 100% of donations will be allocated toward direct program expenses. Sustaining donor support for such programs is imperative for ASH to continue to move hematology forward, particularly during the current period of steadily declining federal support for hematology research through the National Institutes of Health. The ASH leadership has pledged $9 million in Society dollars to support the establishment of the ASH Bridge grant program through the ASH Foundation.

Similar Private Companies By Industry

Company Name Region
Provena Foods Inc. United States
Hughes Satellite Systems HoldCo. United States
Banner Pipeline Company, L.L.C United States
Graphite Design International, Inc United States
JM Associates, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact American Society Of Hematology, please visit www.hematology.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.